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PERSPECTIVES IN CLINICAL NEPHROLOGY
Commerce in transplantation in Third World countries
Chronic renal failure is a devastating medical, social and
economical problem for patients and their families. The true
incidence of advanced renal failure requiring renal replacement
therapy is not known. Data from ESRD registries maintained in
the advanced countries put the incidence between 98 to 198 per
million population/year [1—3]. In the absence of any data collec-
tion facility in the Third World countries, it is difficult to estimate
the magnitude of this problem with any degree of accuracy. Most
of the reported data are only rough estimates based on personal
experience. There is no reason to believe that the incidence of
ESRD is lower than that reported from the advanced nations. A
significant difference which has emerged is that the patient
population entering renal replacement therapy (RRT) programs
in developing countries is much younger compared to that in
Europe and USA. The mean age of patients initiated on ESRD
therapy in the USA is 62 years [1], which sharply contrasts with
Indian patients where the mean age is only 42 years [4].
Uremia therapy: Treatment costs
The treatment of ESRD entails a choice between two basic
therapies: dialysis and transplantation. The factors which influ-
ence this choice include the financial status, availability of medical
facilities, local dialysis and transplant practices and the family and
the social support. During the last decade, access to uremia
therapy has become unrestricted in most industrialized nations
[1]. The individual patients do not have to bear the cost of
treatment, which is met with by well-organized national or private
insurance programs such as are found in the USA, Japan and most
European nations, or by the National Health Service as in the UK,
Australia and New Zealand. In contrast, a dual healthcare system
operates in the developing countries. In the government run
hospitals, the patients can get free medical advice but the state
provides only the most basic medical facilities free of cost. The
patients have to buy most of the drugs and disposables from an
open market. Because of the poor economic conditions, these
countries devote only a small proportion of their gross national
product on the national healthcare. For example, with a per capita
GNP of $400US, India spends about $6US/person/year (1.5% of
the GNP) on health care. For the government, ESRD treatment
does not rate as a high priority compared to population control,
eradication of communicable diseases, family welfare and nutri-
tional supplementation programs. There are no national or pri-
vate health insurance schemes. Treatment costs are reimbursed
only to a minority of patients by their employers; others have to
rely upon family or social support to pay for medical services and
supplies. For a population of 900 million there are 60 government
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institutions with facilities for dialysis, and a fifth of these carry out
renal transplants as well. In the private sector, there are 125
dialysis centers, with a third of these equipped to do renal
transplantation. The experience of other developing nations is no
different [5—7]. Martinez and Donkervoort [8] and Wing [91 have
demonstrated a significant relation between the number of kidney
transplants per million population and the per capita income in
various countries in South America and Europe. Whereas around
56 to 60% of all ESRD patients in the USA and Europe are being
treated by hemodialysis, such centers are severely limited in
number and are located only in major Cities fl the developing
countries.
Whereas long-term maintenance hemodialysis has become cur-
rently accessible, at least to populations in large cities in some
countries in South America and North Africa, this type of facility
is almost non-existent in most countries in Southeast Asia and
Central Africa. The capital costs of setting up a dialysis unit are
very high and finances are severely limited. The existing units have
outdated machinery and poorly trained staff. This culminates in a
high complication rate, and long-term survivors on maintenance
dialysis are virtually unknown. Some countries like Mexico have
tried to overcome this problem by encouraging active continuous
ambulatory peritoneal dialysis (CAPD) programs [10], but the
data on the long-term success of this modality from Mexico are
still not available. The problems hampering the success of CAPD
iii developing countries include: (i) lack of education and compli-
ance among patients, and (ii) the hot and humid climate and poor
hygienic conditions that increase the risk of infection [11].
Renal transplantation: Obstacles
In the absence of adequate dialysis facities, renal transplanta-
tion remains the only hope of survival for ESRD patients in the
developing countries. In the pre-cyclosporine era, living-related
donor transplants were preferred the world over since both short-
and long-term results were superior to cadaver organs under
conventional immunosuppressive therapy. Following the discov-
ery of cyclosporine, the results of cadaver transplants improved to
such a degree as to rival live-related transplants between well
matched donor-recipient combinations. Currently about 75 to
80% of all transplants in the economically advanced countries are
being performed using kidneys from cadaveric donors [1—3].
Recipients over a wide geographic area are placed on a waiting
list, and the kidneys are made available to the most suited
recipients, taking a number of factors into account, including the
length of waiting time, degree of HLA match and the medical
need [12].
The situation is quite different in the developing countries. For
example, it has been estimated that there are at least 90,000 new
patients with ESRD who require renal transplant therapy every
year in India. With increasing health awareness, more and more
patients with ESRD now seek renal replacement therapy in the
hope of returning towards normal health. However, only about
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3,500 transplants are being performed annually at this time. Data
from other developing countries also reveal a big gap between the
number of patients requiring a transplant and those who manage
to receive one [4—8]. The vast majority of such patients are
therefore destined to die for want of appropriate treatment.
Acording to a recent estimate, over 100,000 Asians including
63,998 in China, 11,567 in Taiwan, 9,000 in Korea, 3,780 in Saudi
Arabia, 3,200 in India, 1590 in Hong Kong, 1,213 in Singapore and
1,119 in Thailand are awaiting kidney transplantation (K. Ota,
personal communication).
The establishment of organ sharing networks in the advanced
nations has led to a steady increase in the numbers of ESRD
patients receiving transplants. However, this has been more than
offset by the growth in demand for these organs. Patients on a
Eurotransplant list have to wait for an average of 3.5 years for an
organ. Each year, 5% of kidney patients and 15 to 20% of those
needing other organs die while on the waiting list. In the USA,
while the number of people waiting for an organ rose from 28,000
in 1988 to 50,000 in 1993, the number of cadaver renal transplants
has reached a plateau at about 10,000 per year. Patients requiring
a kidney transplant wait an average of 520 days before receiving
this life saving treatment. According to Coalition on Donation, 8
to 10 people die each day waiting for a transplant [13J, and the
shortage of organs is considered to be the major obstacle. A
number of these patients are not willing to wait indefinitely for a
cadaver graft, and after learning about the practice of paid
transplants, they often travel to Third World countries with the
sole purpose of receiving an unrelated live-donor allograft.
Living donors
In Western countries, the success of cadaver transplants has
seriously questioned the justification for using living-related do-
nors. Doubts have been expressed whether a healthy individual
should be subjected at all to a procedure which would do him or
her no good and yet expose the individual to the potential risk of
surgery and loss of a kidney. Developing countries with almost
non-existent cadaver transplant programs derive solace from the
substantial experience that has accumulated over the years with
living donors. Death or major post-operative complications have
been reported only rarely. A recently published 45-year follow-up
of soldiers who had undergone uninephrectomy following injuries
in the Second World War has shown no long-term complications
of living with a single kidney [14]. In a Gallup poll conducted to
study the psychological reactions, 93% of parents showed their
willingness to donate their organs to their children, and up to 57%
would donate to their friends [15]. Combined with these observa-
tions, a better short- and long-term graft survival has further
ensured that living-related donations would continue to be both
medically and ethically justifiable. In the absence of long-term
dialysis facilities or organized cadaver donor programs, the trans-
plant teams and the patients in developing countries seek help
from living related as well as unrelated donors. The use of
unrelated donors has led to the emergence of a new ethical
dilemma of commerce in transplantation.
Even though altruistic living donation is considered as an act of
supreme charity, medical opinion is sharply divided over the use
of unrelated organ donors. Most centers in the West agree that
living donors who have a close relationship with the recipient,
such as a spouse or a life-long friend, and who are motivated by
love and concern for the recipient, may be accepted in the absence
of a suitable first degree relative. The routine advocacy of spousal
transplant is fraught with the potential of exploitation in a growing
society. For example, in certain orthodox Indian communities,
wives traditionally play a subjugatory role to their husbands and
frequently suffer emotional blackmail if the husband needs an
organ. Some patients are known to have married brides with
matching blood groups with the sole aim of getting a kidney. On
the contrary, instances of husbands volunteering to donate organs
for their wives are few and far between.
Trading in organs: Historical aspects
Commerce in organ transplantation is not unique to the
developing world. In the early 1980s, the export of several
hundred cadaver kidneys for transplantation in wealthy people in
distant countries in preference over local patients came to light in
the USA. The issue was widely debated in both the transplant
community and general public. To check the growing menace of
commercialization of a noble act, the Council of the Transplan-
tation Society put forward a number of guidelines regarding use of
living donors for transplantation and specifically prohibited solic-
iting of unrelated donors for profit [16]. A special resolution
adopted by the Society recommended that no transplant surgeon
or team should be involved directly or indirectly in the buying or
selling of organs/tissues or in any transplant activity aimed at
commercial gain to him- or herself or an association, hospital or
an institute, and that violation of these guidelines by any member
of the Transplantation Society could lead to expulsion from the
Society. The World Health Organization (WHO) [17] also en-
dorsed these guidelines and added that "in light of principles of
distributive justice and equity, donated organs should be made
available to patients on the basis of medical need and not on the
basis of financial or other considerations." At the same time,
vigorous attempts were started to reach a consensus on the
definition of death so as to facilitate removal of organs for
transplantation. In 1990, a Harley Street physician who arranged
transplant operations in which four Turks were paid between
£2500 and £3360 each for their kidneys, was struck off the medical
register by GMC of Great Britain with the observation that his
conduct brought "disgrace upon (him) self and dishonour upon
medical practice in the United Kingdom" [18].
Recognition of the concept of brainstem death was an impor-
tant milestone in clearing the legal and ethical hurdles for cadaver
transplantation. Most developed countries quickly recognized this
concept and brought in legislation incorporating the definition of
brainstem death to define a beating heart cadaver, and expressly
forbidding acquisition or transfer of human organs for "valuable
consideration." Developing countries have been slow in bringing
in similar laws, and in many countries these do not exist at all.
Even though commercialization is prohibited in some of the Latin
American countries, the law states that organs can be donated to
anybody in case of "medical need," which appears to provide a
legal loophole for unrelated transplants. In India, the Human
Organ Transplantation Act banning trade in organs has recently
been passed by the Parliament and has been notified officially in
February 1995. The registration of at least two medical practitio-
ners has been cancelled because of their involvement in commer-
cial transplantation. A number of Asian countries, such as China,
Japan, Malaysia, Bangladesh and Pakistan do not yet have an
organ transplant law.
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Living-unrelated donor transplants in India
Transplants between genetically unrelated living donor-recipi-
ent pairs were first performed in India in the mid 1970s [19]. In
the beginning, these were confined to cases where a suitable
living-related donor was not available, and it is not known whether
any commercial transaction took place between donors and
recipients. However, the practice grew many-fold after the intro-
duction of cyclosporine in India in the mid 1980s. The rules of
marketplace brought the demand and supply together, and with
the help of an intermediary this became a growth industry. Over
the years, these transplants have brought into sharp focus the
frightening spectre of fraud, coercion and rampant commercial-
ism. Organs started getting sold like commercial goods, and
wealthy people who could afford them were able to receive the
much needed transplants after paying a price. According to one
estimate, more than 2000 kidneys were taken from living unre-
lated donors and sold in the metropolitan cities of India in 1991
[20], a number which grew to over 3500 in 1994, involving a
turnover of over 25 million US dollars. The organ recipients who
come to these centers are not only from within the country but
also from overseas, including those from the Middle East, Europe,
Canada, Singapore, Hong Kong, Thailand, Turkey, Malaysia,
Philippines, Pakistan and Bangladesh. Such patients seek treat-
ment from these centers for quick and cheap (by their standards)
transplants, either because they do not have any suitable related
donors or because they do not want to wait indefinitely on dialysis
to get a cadaver organ. For example, between 1976 and 1993, 1261
Saudi Arabian patients received renal transplants overseas, of
which 622 (49.3%) were done in India, all with living unrelated
donors [21].
The success of this enterprise has led to mushrooming of a large
number of private backstreet clinics where such clandestine
transplants are performed by unscrupulous doctors. Many of these
clinics lack the most basic sanitary facilities. Most of the donors
are illiterate drug abusers who live in abject poverty under poor
hygienic conditions. Cases of transmission of HIV and hepatitis
infections through transplanted organs have been reported both
in India and abroad [22—26], Daar [22] reported a 1:18 incidence
of HIV infection in Arab recipients who underwent paid donor
transplants in Bombay. Over a five year period, 150 Singaporeans
who had travelled to India or China for living unrelated trans-
plantation were admitted to Singapore General Hospital with
hepatitis or AIDS, with nine deaths to date. Sever et al [23]
followed up 34 Turkish patients in their hospital at Istanbul who
had undergone transplants in India with kidneys purchased
through agents. Out of these, two patients who were known to be
HBsAg negative before transplant developed evidence of hepati-
tis B infecion two and four months after transplant, and another
three developed falciparum malaria. None of these patients had
received any blood transfusion during or before surgery, and the
infections were thought to have been transmitted through the
allografts. One patient developed urinary tract infection with
Aspergillus and another developed acute renal failure 30 days
after transplant. Graft biosy in this patient showed invasion with
mucor hyphae and the patient died despite graft nephrectomy.
There was an unusually high incidence of surgical complications
as well. One patient came with an open wound and on explora-
tion, a gauze was found lying over the graft. The authors have seen
a patient who had developed HIV infection two months after a
paid donor transplant.
The total cost of transplantation in the Indian centers involved
in unrelated live donor transplants has varied from $8,000 to
$12,000US, which includes donor and recipient evaluation, sur-
gery, pre- and post-transplant hospitalization and broker's fees.
Patients are hospitalized for a short period of time to lessen the
costs and increase the profits; hence the donor and recipient
work-up is often incomplete. In this sort of practice, the doctors
are often abetted by desperate recipients who are willing to run
any number of risks to avoid certain death. In the case of patients
followed up by Sever et al [23], the pre-transplant work-up took
between 3 and 25 (mean 11.1) days and the post-transplant
in-hospital stay ranged from 6 to 25 (mean 15.3) days. We have
seen a patient who became unconscious on his way home 12 days
after an unrelated transplant. His chest roentgenogram and
cerebrospinal fluid examination showed evidence of disseminated
tuberculosis. He died within 24 hours of arrival at our Institute,
and the autopsy revealed the presence of widespread tuberculosis.
For recipients who want such transplants to be done in their
own countries, the agents at times have organized "kidney tours"
to the Middle East, Egypt and Europe. Donors have been taken to
these countries and surgery is performed with the help of conniv-
ing doctors, and the donors come back after receiving their
reward. This was first indicated in a letter written by the Saudi
Arabian Consul General in Bombay to the Bangalore police in
1992. The agent, however, has yet to be identified.
In India, it has been a common practice to solicit kidneys
through newspaper advertisements promising suitable payment as
well as a proper postoperative care. To give such payments an air
of respectability, the term "rewarded gift" was coined whereby the
donor has to sign an affidavit stating that the donation was being
made out of "deep love and affection for the patient." Thiagarajan
and Reddy [27], while reporting a three-year graft and patient
survival of 69% and 74%, respectively, following paid kidney
donation, argued that the consent obtained from a related donor
under "emotional pressure" was no better than the one after a
financial inducement. The proponents also argue that the sense of
fulfillment that the related donor gets after an act of donation can
be compared with the satisfaction a paid donor gets by improving
his or her family's standard of living. Other arguments that are
often advanced in favor of paid unrelated transplants are: (1) that
a paid donor uses the benefit (money) obtained by contracting his
kidney to do good to a third person, such as, settling a family debt,
arranging the dowry for his sister's marriage, etc., thus justifying
the principle of "indirect altruism;" and (2) that the wealthy
recipients, in addition to paying money to the donors, also feel
obliged to provide additional relief to an impoverished society,
thus exhibiting a sense of "mandated philanthropy." The fact
remains that after the actual process of gaining a kidney is over,
the "indirect altruism" or "mandated philanthropy" all vanish.
These phrases therefore are only an attempt to put a veil over the
ugly commercialism behind the practice. In most cases, these
donors are addicted to drugs or alcohol and find this practice as an
easy way to raise money that they burn up in no time. In fact,
instances of those who have used this money to their advantage
are only few and far between. An occasional death of a donor does
momentarily shake them up, but is soon forgotten.
Though horror stories about paid unrelated donor transplants
have appeared in the lay press from time to time, in the absence
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Table 1. Kidney transplantation: Donor source in Asian countries (1991 to 1993)"
Country Total Living Related Unrelated Spouse Cadaver
India 7250 7250 (100) 2350 (32.4) 4500 (62.1) 400 (5.52) 0 (0)
P.R. China 5568 0 (0) 0 (0) 0 (0) 0 (0) 5568 (100)
Korea 2312 2236 (96.7) 1204 (52.1) 947 (41) 85 (3.6) 76 (3.3)
Pakistan 1210 1210 (100) 700 (57.9) 500 (41.3) 10 (0.8) 0 (0)
Japan 1165 752 (64.5) 709 (60.9) 0 (0) 43 (3.6) 413 (35.5)
Saudi Arabia 784 562 (71.7) 337 (43) 225 (28.7) 0 (0) 222 (28.3)
Taiwan 461 55 (11.9) 55 (11.9) 0(0) 0(0) 406 (88.1)
Philippines 334 273 (81.7) 266 (79.6) 6 (1.8) 1(0.3) 61(18.3)
Malaysia 292 288 (98.6) 104 (35.6) 184 (63) 0 (0) 4 (1.4)
Thailand 236 69 (29.2) 69 (29.2) 0 (0) 0 (0) 167 (70.8)
Hong Kong 159 64 (40.3) 59 (37.1) 0 (0) 5 (3.2) 95 (59.7)
Singapore 192 64 (33.3) 54 (28.1) 10 (5.2) 0(0) 128 (66.7)
Oman 112 112(100) 19(17) 93(83) 0(0) 0(0)
Indonesia 72 72 (100) 72 (100) 0 (0) 0 (0) 0 (0)
Bangladesh 26 26 (100) 26 (100) 0 (0) 0 (0) 0 (0)
UAE 20 20 (100) 19 (95) 0 (0) 1(5) 0 (0)
Figures in parentheses are percentages.
a Data presented at the XV World Congress of the Transplantation Society, Kyoto, Japan, September 1994
of any legal safeguards, the practice has continued unabated. A
case was reported in 1989 when a patient was operated upon in a
hospital in Bombay for peptic ulcer, but was discovered to have
undergone a nephrectomy. In 1992, the Delhi Police registered
the case of a professional blood donor who claimed that one of his
kidneys had been removed without his consent at a privately run
hospital. Another example of this reprehensible practice that
came to light at about the same time was the fraudulent removal
of kidneys and eyes from leprosy patients coming for treatment at
a Leprosy Institute. These patients were allegedly told that it was
essential to remove some of their organs in order to prevent the
spread of leprosy in their body and the organs were later sold to
rich patients. Public and media interest in this trade exploded in
February 1995 when a major racket was unearthed in the south
Indian city of Bangalore, where several hundred persons were
brought to one of the hospitals to donate blood. The donors were
illiterate manual laborers with little knowledge about the process
of blood donation. They were apparently told that blood would be
drawn from their abdomens under anasthesia. They were paid a
sum equivalent to $200US each and sent home after a few days.
This came to light only after one such donor underwent a medical
examination at another health facility for some unrelated com-
plaint. Media attention focused on this grisly trade and subse-
quent investigations led to the discovery of a number of "organ
mafias" in various cities in South India. The central figure in such
a racket is usually the broker or a middle man who maintains the
vital link between the doctors/hospitals and the donors. Since the
trade thrives on ignorance about organ donation, the donor is
usually an illiterate, unemployed person from a poor socioeco-
nomic background who is desperately in need of money. After
obtaining the blood group and HLA reports of the potential
recipient, the broker comes back with a list of prospective donors
with matching blood groups. It has been reported that the agents
often fudge the reports and show a good HLA match, which
would be exceptional in the case of unrelated donor. Apart from
the expenses incurred on the surgery, the patient pays the middle
man a sum which may range from $1000 to $2500US, depending
upon the rarity of the blood group and the "degree" of HLA
match.
The practice has become so common in some transplant centers
that it has given birth to a number of "kidney colonies" from
where professional agents are known to bring people for donating
kidneys to wealthy donors with no questions asked. The first such
colony was uncovered near Madras in the south Indian state of
Tamil Nadu in 1992. Kidney donation is a household concept in
that colony, and according to conservative estimates, over 5,000
people have already donated their kidneys for financial consider-
ations. On average, one out of eveiy 10 houses has at least one
occupant who has donated his or her kidney. In a number of
instances, more than one member of the family have donated their
kidneys. These villagers are manual laborers who work on a daily
wage basis and lead a hand-to-mouth existence. They think of
their kidneys as a kind of financial reserve, much like a bank
balance. Their poor socioeconomic condition compels them to
borrow money from local loan sharks at high interest rates in
times of crisis like illness, raising of dowry, etc. The interest on
these unpaid debts eats away their wages, forcing them to use up
their "renal reserve." There are a number of instances where the
lender, upon learning that the debtor has gone to donate a kidney,
has gone to the hospital and collected the entire amount himself,
leaving the donor with a pittance.
Paid transplants in other developing countries
The phenomenon of unrelated transplants has also been re-
ported from Philippines, Egypt, Iran, Korea, Pakistan, Malaysia,
Oman, Saudi Arabia (Table 1), and a number of Latin American
countries. In a report published recently, under-the-table paid
donation was suspected in at least 5 out of 13 Latin American
countries [7]. It has been estimated that 10 to 40% of all
transplants in Brazil and Chile are done using paid donors despite
the existence of legislation banning sale of organs. In Argentina,
an investigation into irregularities in the functioning of a mental
health institute revealed that patients were being killed in an
organized manner and their organs were being sold for monetary
gain [28]. In view of the clandestine nature of such acts, it is
difficult to get an accurate estimate of the extent of the problem.
There have also been reports of removal of organs from executed
prisoners in Taiwan, and concerns have been raised that the law
on the diagnosis of brainstem death is being contravened to
ensure organ supply [29]. The Chinese Medical Association is not
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ready to discuss this issue. Similar instances have come to light
from People's Republic of China, which does not have a legal
definition of brainstem death. Executed prisoners are the major
source of donor kidneys for the cadaver transplant program in the
People's Republic of China (Table 1). Sales of organs from these
prisoners for use in transplantation adds a new dimension to the
concept of cadaveric transplantation in that country.
Ethical and religious issues
The issue of the advisability of allowing the practice of paid
unrelated transplants to continue in the Third World countries
has been the subject of major debates in several national and
international forums. Though almost all nephrologists and trans-
plant surgeons from wealthier nations are unanimous in con-
demning the practice in their own countries, many of them stop
short of expecting the same ethical standards from the developing
nations [30, 31]. We feel that this is not the correct approach and
that medical as well as ethical standards should be uniform
throughout the world. Moreover, continuation of the unrelated
transplant programs even in a limited manner is likely to hamper
the growth of living related as well as cadaver donor based
programs. In the series reported by Sever et al [23],at least four
patients, who had suitable living-related donors, chose to undergo
paid donor transplants. Despite all difficulties, we feel that
encouragement to the cadaver donor program is the only solution
to this ethical dilemma, though concerns have been raised about
the acceptability of this program among the general public. In a
survey of 600 persons aged more than 20 years in India, 54%
expressed their readiness to pledge their organs to transplantation
after death, 41% refused and the rest were undecided [32]. The
rate of refusal was highest among the illiterate. Reasons given for
the refusal to donate organs included religious taboos, disap-
proval by relatives, respect for the dead and the fear that the last
rites will be withheld. In Latin America an increasingly positive
attitude towards donation is now being observed.
Most religions now view organ donation as an act of outstand-
ing altruism. The Catholic church was against organ donation half
a century ago, as was expressed by Pope Pius XI in the Littera
Encyclica "Casti Connubi" [331. Subsequently the Catholic church
has brought its religious thinking in line with the reality of clinical
results and the present Pope, John Paul II, defines donation as an
"act of supreme charity" [341. In Islam, ethical and religious
guidelines have been favorable to the donation of organs for
transplantation from living and cadaveric donors. The Third
International Conference of Islamic Jurists held in 1986 in
Amman, Jordan endorsed the definition of brainstem death [22].
Speaking at the First International Congress of Transplantation in
Developing Countries held at Singapore, the President of the
Islamic Religious Council of Singapore advised the Muslim
community to pledge their organs after death. Hinduism believes
in the concept of 'atma' (soul) and 'sharira' (body). Once the soul
has left the body, the latter is thought to be of no worth. Similar
views are held by Buddhists, Objections have never been raised to
organ donation by any Hindu religious leader. Indeed, Ganesha,
a Hindu deity, carries the head of an elephant, which according to
Hindu mythology was transplanted after his own head was cut off
as a child. Incorporation of the nobility of organ transplantation in
the discourses of the religious leaders would go a long way in
molding the public opinion in favor of organ donation. Develop-
ing countries need to launch educational programs to help build
public awareness of the need of organ donation and to encourage
people to tell their families about their wish to donate after death.
Though the Indian Parliament has recently enacted a legislation
banning live-unrelated donor transplants, whether this in itself
would bring the commercial sale of organs to a complete halt, is
yet to be seen. Most of the states in the country have yet to adopt
the bill by passing it in their respective legislatures. Besides,
establishing a cadaver transplant program in a developing country
like India faces several other major hurdles, and a number of steps
are necessary before a kidney retrieved from a cadaver source can
be transplanted into a recipient. It is obvious that most of the
requirements cannot be met with under the existing conditions in
a largely inefficient state-run healthcare delivery system. Organ
transplant does not rank high on the government's list of priori-
ties. According to official figures, there were 60,000 road fatalities
in 1993 in India. Theoretically, this should end the problem of
organ shortage. However, a vast majority of hospitals in India are
not equipped to effectively utilize this source. The organ procure-
ment and transplantation would depend not only on the initiative
of individual transplanting physicians, but also the crucial role of
the cooperating intensive care units. A low-level of education of
the healthcare professionals and the general public regarding
cadaver donations is likely to lead to low organ procurement rate.
Attempts made to organize projects for organ procurement and
transplantation in countries like Argentina, Brazil, Colombia and
Chile have proved to be grossly ineffective mainly due to lack of
finances and committed personnel.
Conclusion
There is a feeling of repugnance when one thinks of the human
body as a commodity for sale, reflecting the coercion brought
about by abject poverty. Even though we cannot put an end to
poverty, we must not condone such malpractices that lessen
others' respect for the segment of society that is forced into such
unethical activities. Kidney selling, therefore, is grossly exploit-
ative, akin to a form of enslavement. Endorsing such a practice
would mean that the rich would always be able to "buy" health
from the poor, and this two-tier health delivery practice would
continue to prevail in Third World countries.
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